Related Experiment Video
Updated: Feb 3, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Deciphering the transcription factor-microRNA-target gene regulatory network associated with graphene oxide
Masoumeh Farahani1, Mostafa Rezaei-Tavirani2, Hakimeh Zali3
1a Faculty of Paramedical Sciences , Shahid Beheshti University of Medical Sciences , Tehran , Iran.
Abstract:
Graphene oxide (GO) has recently emanated as a promising material in cancer treatment. To unveil the underlying mechanisms of microRNAs (miRNAs) and potential target genes involved in GO cytotoxicity, we firstly compiled GO-related miRNAs and genes in human cancer cell lines treated with GO from public databases and published works. Besides miRNAs as post-transcriptional regulators of gene expression, transcription factors (TFs) are also the main regulators at the transcriptional level. In the following, we explored the regulatory relationships between miRNAs, target genes, and TFs. Thereafter, a gene regulatory network consisting of GO-responsive miRNAs, GO-responsive genes, and known human TFs was constructed. Then, 3-node regulatory motif types were detected in the resulting network. Among them, miRNA-FFL (feed-forward loop) was identified as a significant motif type. A total of 184 miRNA-FFLs were found and merged to generate a regulatory sub-network. Pathway analysis of the resulting sub-network highlighted adherens junction, focal adhesion, and TGFβ signaling pathways as the major pathways that previous studies demonstrate them to be the affected pathways in GO-treated cells. Functional investigations displayed that miRNAs might be involved in the control of apoptosis through disruption of cell adhesion in response to cytotoxicity. Moreover, GO-cell interactions can lead to miRNA targeting of genes (i.e. Rac1 and RhoA) involved in the cytoskeleton assembly process. These specific toxic properties support biomedical applications of GO, especially for cancer therapy.
Insights
Graphene oxide (GO) shows promise in cancer therapy by affecting microRNAs (miRNAs) and genes. This study reveals how GO-induced cytotoxicity involves regulatory networks and pathways crucial for cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Biology
Background:
- Graphene oxide (GO) is a novel material with potential applications in cancer therapy.
- Understanding the molecular mechanisms of GO's effects on cancer cells is crucial for its therapeutic development.
Purpose of the Study:
- To investigate the roles of microRNAs (miRNAs) and their target genes in graphene oxide (GO) induced cytotoxicity.
- To explore the regulatory network involving miRNAs, target genes, and transcription factors (TFs) in GO-treated cancer cells.
Main Methods:
- Compiled GO-related miRNA and gene data from public databases and literature.
- Constructed a gene regulatory network including GO-responsive miRNAs, genes, and TFs.
- Identified and analyzed miRNA-feed-forward loops (FFLs) and associated pathways.
Main Results:
- A significant gene regulatory network was constructed, highlighting miRNA-FFLs as key motifs.
- Pathway analysis revealed that adherens junction, focal adhesion, and TGFβ signaling pathways are prominently affected.
- miRNAs were found to potentially regulate apoptosis by disrupting cell adhesion and targeting cytoskeleton-related genes like Rac1 and RhoA.
Conclusions:
- Graphene oxide exerts cytotoxicity through complex regulatory networks involving miRNAs and TFs.
- GO-induced cellular effects impact critical pathways related to cell adhesion and cytoskeleton organization.
- These findings support the biomedical applications of GO in cancer therapy.
More Related Videos
Related Concept Videos
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Transcription Elongation Factors
MicroRNAs
Cis-regulatory Sequences
General Transcription Factors

